Top Biomed Stock Signal: MLYS
Report Date: 01-28-2024
Symbol: MLYS - Mineralys Therapeutics, Inc.
Sector:
Industry:
Top Biomed Stock Signal: MLYS
Mineralys Therapeutics, Inc. (MLYS)
150 N. Radnor Chester Rd.
Radnor, PA 19087
Phone: 888-378-6240
Website: https://mineralystx.com
CEO: Mr. Jon Congleton
NASDAQ, NASDAQ Global Select
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.